English | Español
Amanda Rupp | Oct 5, 2016

Keynote speakers announced for 2016 Rare Diseases and Orphan Products Breakthrough Summit
Amanda Rupp | Oct 4, 2016

NOF's online support community surpasses 30,000 members
Amanda Rupp | Oct 4, 2016

Health leaders release One Brave Idea research award
Amanda Rupp | Oct 4, 2016

NIH honors 12 environmental health research leaders
Amanda Rupp | Oct 3, 2016

American Diabetes Association supports FDA approval of hybrid insulin delivery system
Amanda Rupp | Oct 3, 2016

FDA outlines risks of homeopathic teething gels, tablets
Amanda Rupp | Oct 3, 2016

Amgen to present new data concerning melanoma, metastatic colorectal cancer treatments
Amanda Rupp | Oct 2, 2016

FDA approves Ilaris expansion for three rare diseases

Trending
+ Pharmaceuticals
Patient Daily | Jun 30, 2025

PhRMA public affairs senior director on 340B program: 'PBMs took $140 billion in rebates and fees, driving up American medicine costs'
+ Pharmaceuticals
Patient Daily | Jun 25, 2025

Neurosurgeon at the University of California: ‘340B is being exploited for profit, not patient care’
+ Pharmaceuticals
Patient Daily | Jul 1, 2025

PhRMA chief public affairs officer on 340B drug pricing: ‘Lowering drug prices for U.S. patients starts by reining in middlemen’